Congratulations to Muhammed Murtaza who was recently awarded a three-year, $1 million Exploratory/Developmental Cooperative Agreement Phase II (UH3) Award from the National Cancer Institute. The grant will support his study titled “Treatment monitoring in early and locally advanced breast cancer using circulating tumor DNA analysis.” Read more.
Read the full article at: https://www.surgery.wisc.edu/2024/07/25/murtaza-awarded-nih-grant-to-validate-new-blood-test-to-improve-monitoring-of-breast-cancer-during-treatment/